Clinical Trial Update: VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of VTX002 versus placebo for moderately to severely active ulcerative colitis has results posted; trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VTX002

Snippet

Sponsor: Oppilan Pharma Ltd | Conditions: Colitis, Ulcerative | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-13